Sodium benzoate

Sodium benzoate (CAS No.: 532-32-1) is a widely utilized small-molecule compound classified as a pharmaceutical excipient and biochemical modulator, commonly employed in research settings for its antimicrobial and preservative properties as well as its functional influence on formulation stability and processing characteristics. Beyond its auxiliary role, sodium benzoate has been shown to act as a D-amino acid oxidase inhibitor and to modulate cellular signaling pathways, notably activating NF-κB signaling and promoting apoptosis under specific experimental conditions, thereby contributing to studies of cell survival, inflammatory responses, and stress-related signaling cascades. It has also been reported to exert immunosuppressive effects and display potential reproductive toxicity in certain model systems, highlighting its relevance in toxicological and safety pharmacology investigations. In vitro studies typically explore its biological activity across low micromolar to millimolar concentration ranges depending on the assay context, while in vivo or cell-based applications vary according to experimental design. Sodium benzoate is frequently used in mechanistic studies of colon cancer progression and in models of immune-related disorders, where it serves as a tool compound to interrogate molecular pathways, cellular responses, and interactions affecting absorption, distribution, metabolism, and elimination processes of co-administered agents.